These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 13898634)

  • 1. A quantitative appraisal of the value of vasodilators in occlusive peripheral arterial disease.
    GILLESPIE JA
    Bull Soc Int Chir; 1962; 21():69-72. PubMed ID: 13898634
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the use in medical therapy of peripheral arteriopathies of an enzymatic complex in association with a peripheral vasodilator].
    STARACE G; NOFERI A
    Minerva Cardioangiol; 1959 Oct; 7():545-50. PubMed ID: 13833816
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new vasodilator in the functional therapy of peripheral arteriopathies: 1-(p-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-propanol HC1].
    FERRANTE G; GRASS IM; NEGRO G
    Minerva Cardioangiol; 1960 Jun; 8():288-95. PubMed ID: 13822372
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of a product of esterification of mandelic acid with 3,5,5-triethylcyclohexanol (cyclospasmol) in the treatment of peripheral arteriopathy].
    STARACE G; NOFERI A; PADULA R
    Gazz Med Ital; 1960 Apr; 119():133-6. PubMed ID: 13833815
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasodilators and the use of cyclospasmol in peripheral vascular disease.
    MAHL MM
    Angiology; 1961 Sep; 12():432-4. PubMed ID: 13765381
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic trial of a vasodilator in arteriopathy of the extremities. Evaluation of results and discussion on the use of vasodilators in arteritis].
    PIERRON J
    Mars Med; 1960; 97():641-5. PubMed ID: 14432867
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of nylidrin hydrochloride on the skin and muscle temperature of patients with occlusive arterial disease of the lower extremities.
    ROEDLING HA; ROTH GM; SCHIRGER A; GIFFORD RW
    Angiology; 1960 Apr; 11():130-2. PubMed ID: 14438272
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of a new vasodilator agent in management of peripheral arterial insufficiency.
    SAMUELS SS; SHAFTEL HE
    J Am Med Assoc; 1959 Sep; 171():142-5. PubMed ID: 14441294
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasodilator drugs for peripheral vascular disease.
    GOODWIN JF
    Br Med J; 1960 Jun; 1(5188):1800-3. PubMed ID: 13851099
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of peripheral vascular diseases with a new vasodilator agent].
    MARINONI E; ZUCCHI C
    Minerva Cardioangiol; 1960 Dec; 8():597-607. PubMed ID: 13766848
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined vasodilator therapy in peripheral vascular diseases.
    POPKIN RJ
    J Am Geriatr Soc; 1960 Aug; 8():638-43. PubMed ID: 14434109
    [No Abstract]   [Full Text] [Related]  

  • 12. [Duvadilan: a new peripheral vasodilator].
    MARTORELL A
    Angiologia; 1959; 11():241-4. PubMed ID: 14421881
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dilatropon in the treatment of peripheral vascular diseases].
    FABI M
    Arcisp S Anna Ferrara; 1959; 12():75-84. PubMed ID: 13821185
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution to the clinical study of a new vasodilator].
    BENINI P; COSSU G
    Minerva Chir; 1960 Apr; 15():429-44. PubMed ID: 13798881
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of peripheral arteriopathies with the combination of a vasodilator and a vasotonic].
    SAVIO O
    Minerva Med; 1960 May; 51():1962-6. PubMed ID: 14442064
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral vasodilation: methods of evaluation and the correlation with clinical practice.
    KAINDI F
    Angiology; 1960 Feb; 11():15-20. PubMed ID: 14404025
    [No Abstract]   [Full Text] [Related]  

  • 17. [Demonstration on a trial treatment with Euclidan injected by the intra-arterial route of severe ischemic conditions of the lower limbs].
    BRUN F; PLAUCHU G; PERRIN A
    Lyon Med; 1962 Jun; 94():1413-25. PubMed ID: 13873962
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of cyclandelate (cyclospasmol) in treatment of circulatory disturbances.
    LESLIE RE
    Tex State J Med; 1960 May; 56():352-6. PubMed ID: 14415999
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution to the study of a pyrimido-pyrimidine derivative].
    LOPEZ MERINO V; ALGARRA GONZALEZ F; PONS ESPANA E
    Med Esp; 1961 Sep; 46():204-13. PubMed ID: 14466606
    [No Abstract]   [Full Text] [Related]  

  • 20. [First notes on the use of a new vasodilator, Caa 40, in leg ulcers].
    DUGOIS P; COLOMB L; GAGNAIRE J
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():213-4. PubMed ID: 13818502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.